Jagadguru Sri Shivarathreeshwara University (JSSU), Mysore, one of the leading universities in India and AlfaGene Biosciences (AGB), USA, a biomedical and biotechnology-focused organization have signed a Memorandum of Understanding (MoU) on July 16, 2009 at New Jersey, USA agreeing to "explore opportunities for cooperation and collaboration with each other in the field of biotechnology and research related work."

The MoU is aimed to create a shared programme for human adult stem cell treatment research and applications, initially focusing on personalized medicine and regenerative therapy for chronic inflammatory diseases and cancers of the gastrointestinal tract such as Crohn's disease, ulcerative colitis, and colon cancer.

JSSU's Vice-Chancellor, Dr. B Suresh, signed this "Memorandum of Understanding" along with AlfaGene's CSO Dr. Asit Panja, while visiting AlfaGene's stem cell research facility in Somerset, New Jersey (US).

Those who were present during the signing of the MoU included Sreedhar Venkatraman, Controller of AlfaGene, Ashish Mahajan from business development department of AlfaGene, Dr. Muthusamy Shanmugam, Ph.D., JSSU Alumni, and Dr. Satish Palaniappan, Ph.D., also a JSSU Alumni.